Datasets
Buyer room
LIFESCIENCES.DIGITALManage supplier listing
Advarra (Braid — Study Design / Site ID) — A digitised clinical-trial OPERATIONS dataset accrued as byproduct of Advarra's own IRB and clinical-trial-management systems: 170,000+ protocol-related documents and operational records from 30,000+ studies across 3,500+ sponsors. Contents include full protocol design structure (eligibility criteria text, schedule of assessments, visit procedures and endpoints), longitudinal protocol-amendment history with the reason behind each amendment, regulatory-review and study-startup milestone cycle times, enrollment trends and attainment, and site-level per…
A digitised clinical-trial OPERATIONS dataset accrued as byproduct of Advarra's own IRB and clinical-trial-management systems: 170,000+ protocol-related documents and operational records from 30,000+ studies across 3,500+ sponsors. Contents include full protocol design structure (eligibility criteria text, schedule of assessments, visit procedures and endpoints), longitudinal protocol-amendment history with the reason behind each amendment, regulatory-review and study-startup milestone cycle times, enrollment trends and attainment, and site-level performance (enrollment ease or difficulty, competition for patients, repeatability). Harmonised to standardised ontologies across systems, and by design contains no clinical or patient-identifiable data — it is study metadata and aggregated operational data.
Scale 170From 20 yearsAsset class Equities
Sample, licence terms, pricing and eval results when Lifesciences publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about Lifesciences, answered from this page.
Advarra (Braid — Study Design / Site ID) — A digitised clinical-trial OPERATIONS dataset accrued as byproduct of Advarra's own IRB and clinical-trial-management systems: 170,000+ protocol-related documents and operational records from 30,000+ studies across 3,500+ sponsors. Contents include full protocol design structure (eligibility criteria text, schedule of assessments, visit procedures and endpoints), longitudinal protocol-amendment history with the reason behind each amendment, regulatory-review and study-startup milestone cycle times, enrollment trends and attainment, and site-level per…
Lifesciences offers (Alternative, Fundamental, Reference) — 170,000+ protocol-related documents and operational data from 30,000+ studies spanning 3,500+ sponsors, across multiple therapeutic areas, phases and trial types. Because each study carries a longitudinal series of amendments, startup milestones, enrollment time series and site-performance records, structured operational rows plausibly reach 10^7-10^8. The dataset is continuously regenerated — the company states intelligence is produced at each protocol amendment, so this is a live-accruing estate rather than a static archive..
Protocol design optimisation and criteria-simplification evidence (replacing 'amend it later' with prospective design quality); prediction of protocol amendments before first-patient-in, trained on 30,000+ studies' realised amendment histories; startup-timeline and enrollment-attainment forecasting; site selection and feasibility (which sites have realised enrollment for which indications, and at what competition level); visit-schedule burden reduction and patient-retention modelling; training and benchmarking document-AI systems on clinical protocol extraction at scale; regulatory-science research on how design choices propagate into operational failure; sponsor and CRO performance benchmarking.
The data is with 20 years of history.
Coverage spans US; Life Sciences Tools & Services, Application Software; alternative, fundamental, reference; equities.
Lifesciences has not added their own details yet. Not yet on file: